An Interesting Imaging Presentation of a Common Benign Entity: Fibrocystic Changes in a Postmenopausal Patient.
| Autor: | Dang BQ; Radiology, University of Texas Medical Branch, Galveston, USA., Miles B; Radiology, University of Texas Medical Branch, Galveston, USA., Young P; Radiology, University of Texas Medical Branch, Galveston, USA., He J; Pathology, University of Texas Medical Branch, Galveston, USA., Nguyen QD; Radiology, Baylor College of Medicine, Houston, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2023 Mar 17; Vol. 15 (3), pp. e36292. Date of Electronic Publication: 2023 Mar 17 (Print Publication: 2023). |
| DOI: | 10.7759/cureus.36292 |
| Abstrakt: | Fibrocystic changes (FCCs) are common, often benign, breast lesions characterized by adenosis, fibrosis, and cyst formation. These changes are believed to be associated with fluctuating hormone levels and are predominantly found in premenopausal women due to higher levels of estrogen. Certain conditions that cause hormonal imbalances, such as polycystic ovarian syndrome, have also been associated with an increased risk of FCCs. FCCs can occur in postmenopausal women on hormonal replacement therapy but are otherwise extremely rare. Although this condition is primarily considered benign, complex cysts presenting in a rare demographic warrant further evaluation beyond screening mammograms to exclude the possibility of malignancy. In this paper, we present the case of new FCCs in a postmenopausal woman and explore the radiology, histology, carcinogenic potential, treatment options, and potential contributing factors of the condition. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Dang et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|